SEC Form 4 · accession 0001104659-18-003610
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary G Gemignani
Officer — Executive Vice Pres. & CFO
Period of report
Jan 19, 2018
Accepted (ET)
Jan 23, 2018 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $2.40 | Jan 19, 2018 | A | 82,500 | A | — | Jan 19, 2028 | Common Stock | 82,500 | 766,875 | D |
Explanation of responses
- F127,500 of the stock options vest on each of 1/19/2019, 2020 and 2021.